Jiangxi Synergy Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Jiangxi Tonghe Pharmaceutical Co., Ltd. was established in Fengxin County, Jiangxi Province in 2004. The company is located in the scenic Fengxin Industrial Park in Jiangxi, 55 kilometers away from the urban area of Nanchang. It covers a total area of 80000 square meters, with a construction area of 62000 square meters. The second phase of the factory under construction covers an area of 240000 square meters. The factory is built according to GMP standards, with well-equipped factory facilities that meet the international requirements for the production of raw material pharmaceutical products. Mainly engaged in the production of raw materials and intermediates, the production capacity and product quality of the main varieties are at a leading level in China. We have approximately 500 enamel and metal reaction kettles ranging from 50 to 20000 liters, with a total volume of 3 million liters. Tonghe is one of the most strict quality management raw material drug manufacturers in China. The main raw material drugs have DMF documents, and relevant ICH documents such as Q7 have been well implemented, pursuing zero defects and passing official quality system inspections. The main raw material drug varieties pass GMP inspections by official institutions such as NMPA, US-FDA, PMDA, and MFDS, and receive more than 50 user quality audits annually. Our products are exported to over 40 countries and regions around the world, with an export rate of over 95%. Sales in Europe, the United States, Japan, and South Korea account for over 80% of the company's total sales. Strong R&D capabilities are a guarantee for maintaining market competitiveness, continuously launching new products, and obtaining contract processing orders. Tonghe's annual R&D investment accounts for over 6% of sales. The continuous introduction of scientific and technological talents, extensive cooperation with scientific research institutions, and high investment in research and development expenses ensure the continuous improvement of research and development strength. Safety culture is an important component of Tonghe corporate culture. Tonghe Pharmaceutical pursues a safety management model of full participation and teamwork, and promotes integrated EHS management. The company's safety policy is "safety first, prevention first; all hands on, comprehensive management; based on risk management, implement the PDCA cycle model, create a safety environment for team cooperation and employee cooperation, and ensure safe production." Tonghe believes that the responsible EHS concept is an important guarantee for the sustainable development of the enterprise. In the process of development, Tonghe Pharmaceutical has formed a corporate culture with the core values of "seriousness and rigor, honesty and trustworthiness, unity and cooperation, and proactive improvement". Tonghe people treat their work with seriousness and rigor. Secondly, they are serious and rigorous. Thirdly, they have a serious and rigorous behavior habit. They are committed to the pursuit of "promoting first-class management, cultivating first-class talents, producing first-class products, and creating first-class enterprises". Through the unremitting efforts of Tonghe employees, the company is becoming a well-known raw material drug production base. |
| Headquarter | Yichun |
| Establish Date | 4/20/2004 |
| Listed Code | 300636.SZ |
| Listed Date | 3/31/2017 |
| Chairman | Pang Zhengwei. |
| CEO | Pang Zhengwei. |
| Website | www.jxsynergy.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
